Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

  • Condition: Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Pembrolizumab and Vorinostat
  • Number of Patients: 50
  • Published —
This trial investigated the use of pembrolizumab and vorinostat in patients with recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer.
  • Condition: Intermediate-Grade Carcinoma of the Parotid
  • Journal: American journal of otolaryngology
  • Treatment Used: Adjuvant Radiation
  • Number of Patients: 744
  • Published —
This study determined the influence of adjuvant radiotherapy on survival in surgically-managed early stage intermediate-grade mucoepidermoid and acinic cell carcinoma of the parotid.
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Procedure, Biological
  • Participants: 818
  • Start Date: January 13, 2017
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors